Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →33
🟠 Elevated
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
207
Total Claims
$741K
Drug Cost
33
Beneficiaries
$22K
Cost/Patient
Risk Score Breakdown 33/100
Score components are additive. Read full methodology
Peer Comparison vs. 8,541 Hematology-Oncology providers
+632%
Opioid rate vs peers
45.9% vs 6.3% avg
+65%
Cost per patient vs peers
$22K vs $14K avg
+42%
Brand preference vs peers
20.8% vs 14.6% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
🔎 Data Overview
Opioid prescribing rate is 632% above the average for Hematology-Oncology providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
45.9%
Opioid Rate
95
Opioid Claims
$5,527
Opioid Cost
25.3%
Long-Acting Rate
This provider's opioid prescribing rate of 45.9% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 43 claims · $440K
Generic: 164 claims · $301K
Patient Profile
59
Avg Age
49%
Female
4.28
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About